Skip to search formSkip to main contentSkip to account menu

Intravenous bisphosphonates

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
e20007Background: RI is prevalent in MM patients and associated with poor survival and increased costs. IVBPs are recommended to… 
2013
2013
e20665 Background: Cancer patients with BMets are predisposed to skeletal complications. Bone targeted therapies such as… 
Review
2013
Review
2013
192 Background: Bone is a common site of metastatic involvement in patients (pts) with prostate cancer (PC). Bony metastases… 
Review
2011
Review
2011
For many solid tumors, bone is a common site of spread and one that compromises the quality of life of patients. The routine use… 
Review
2010
Review
2010
e19619 Background: Metastatic bone disease is a common complication of several malignancies, including breast cancer, prostate… 
2009
2009
1035 Background: Intravenous bisphosphonates (IV BPs) are safe and effective in reducing skeletal related events in MBC. The… 
Review
2009
Review
2009
Background: Metastatic bone disease, a common complication of malignancy, causes significant morbidity in affected patients…